BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25982582)

  • 1. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
    Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
    Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Clinical Stage I Nonseminomatous Germ Cell Testicular Tumors: A 25-year Single-center Experience.
    Ondrusova M; Waczulikova I; Lehotska V; Zeleny T; Ondrus D
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1015-e1019. PubMed ID: 28673797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in the management of clinical stage I nonseminomatous germ cell testicular cancer.
    Ondrus D; Kajo K; Stastna V; Ondrusova M
    Klin Onkol; 2015; 28(2):112-5. PubMed ID: 25882021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage I testicular seminoma risk-adapted therapeutic management.
    Mrinakova B; Kajo K; Lehotska V; Ondrusova M; Balogova S; Pinakova Z; Novotna V; Usakova V; Fedorkova L; Waczulikova I; Kausitz J; Ondrus D
    Neoplasma; 2021 May; 68(3):613-620. PubMed ID: 33502887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR
    J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
    Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
    World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.
    Boormans JL; Sylvester R; Anson-Cartwright L; Glicksman RM; Hamilton RJ; Hahn E; Daugaard G; Lauritsen J; Wagner T; Avuzzi B; Nicolai N; Del Muro XG; Aparicio J; Stalder O; Rothermundt C; Fischer S; Laguna MP
    Eur Urol Oncol; 2024 Jun; 7(3):537-543. PubMed ID: 37951820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Incidence and Mortality Rates in Patients With Testicular Germ Cell Tumors.
    Palumbo C; Mistretta FA; Mazzone E; Knipper S; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lattouf JB; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Oct; 17(5):e1026-e1035. PubMed ID: 31378580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surveillance or adjuvant treatments in stage 1 testis germ-cell tumours.
    Cullen M
    Ann Oncol; 2012 Sep; 23 Suppl 10():x342-8. PubMed ID: 22987989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of patients with clinical stage I nonseminomatous germ cell testicular cancer: Active surveillance versus adjuvant chemotherapy - single-centre experience.
    Ondrus D; Ondrusova M; Kajo K
    Neoplasma; 2015; 62(1):159-63. PubMed ID: 25023569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.
    Cohn-Cedermark G; Stahl O; Tandstad T;
    Andrology; 2015 Jan; 3(1):102-10. PubMed ID: 25270123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
    Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
    Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
    Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
    J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.